Nydiagnosticeret sukkersyge, højt blodsukker eller en forværring af eksisterende sukkersyge er sjældent rapporteret hos patienter i behandling med protease hæmmere.
New onset diabetes mellitus, high blood sugar or an increase in severity of existing diabetes mellitus has been rarely reported in patients receiving protease inhibitors.